PANews reported on March 15th, citing CNNC, that an IDF military spokesperson stated that the military operation against Iran will continue for at least anotherPANews reported on March 15th, citing CNNC, that an IDF military spokesperson stated that the military operation against Iran will continue for at least another
Israeli military spokesman: Military action against Iran will continue for at least another three weeks.
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
PANews reported on March 15th, citing CNNC, that an IDF military spokesperson stated that the military operation against Iran will continue for at least another three weeks, with thousands of targets still awaiting strikes. IDF spokesperson Defririn stated, "We still have thousands of targets ahead of us. We are prepared, coordinating with our US allies, and the operational plan covers at least until Passover (approximately three weeks later). After that, we have a more in-depth plan that will last for more than three weeks." Defririn indicated that the IDF is not working according to a timetable, but rather to achieve its objectives. He added that Israel's goal is to "severely weaken the Iranian regime."
Market Opportunity
Notcoin Price(NOT)
$0.0004373
$0.0004373$0.0004373
USD
Notcoin (NOT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
LIXTE Biotechnology Advances Precision Oncology with Novel PP2A Inhibitor LB-100
LIXTE Biotechnology Holdings (LIXT) advances precision oncology with LB-100, a PP2A inhibitor enhancing chemo/radiation. Learn about its novel activation lethality
Share
Citybuzz2026/04/25 03:01
Major Legal Face-Off in TerraUSD Collapse: Jane Street Defends Its Role
The post Major Legal Face-Off in TerraUSD Collapse: Jane Street Defends Its Role appeared on BitcoinEthereumNews.com. A tense legal situation is unfolding as Jane
Share
BitcoinEthereumNews2026/04/25 03:30
Nakamoto Announces Actively Managed Bitcoin Derivatives Program Designed to Generate Volatility Income and Hedge Downside Exposure
Program Facilitated by Bitwise Asset Management and Kraken Institutional ServicesNASHVILLE, Tenn.--(BUSINESS WIRE)--Nakamoto Inc. (NASDAQ: NAKA) (“Nakamoto” or
Share
CryptoReporter2026/04/24 23:30
